In preparation for the GHP Annual General Meeting on April 24, the GHP Nomination Committee proposes the election of Dag Andersson as new Board Member. The committee also proposes re-election of all current Board Members; Carsten Browall (Chairman), Bo Wahlström, Elisabeth Hansson, Mikael Olsson and Johan Wachtmeister.
Dag Andersson has a long and solid experience from medtech and life science, most recently from the role as CEO of Diaverum AB during the years 2008-2018, and before that, leading roles in Mölnlycke Health Care AB during the years 1993-2007. Dag Andersson has experience of board work in medtech and life science and is currently a board member of Nolato AB (publ), Terveystalo OY (publ) and chairman of the board of Diaverum Middle Ease. Dag Andersson was born in 1961 and holds an MBA from INSEAD and a BA (Hons) in Business and Commerce from the Stockholm School of Economics. Dag Andersson is independent in his relation to the company and its major shareholders.
The GHP Nomination Committee comprises Thomas Eriksson (Chairman), representing Metroland BVBA, Carl Palmstierna, representing Johan Wachtmeister incl. companies, Erik Hjalmarsson, representing Grenspecialisten förvaltning AB, and Carsten Browall as chairman of GHP Specialty Care AB.
14 March 2019
GHP Specialty Care AB (publ)
Queries should be addressed to:
Carsten Browall, Chairman of the Board, Tel: +46 702 55 65 32
GHP is an internationally active health care provider that operates specialist clinics in a select number of diagnostic areas through the application of a business model that is unique in the health care industry, where leading doctors and medical staff become partners and shareholders. Each clinic specialises in a particular patient group, and this leads to increased efficiency and higher quality. This is the cornerstone of GHP’s business philosophy – “Quality through specialisation”. GHP shares are traded on the Small Cap list of Nasdaq Stockholm under the ticker symbol “GHP”.
GHP Specialty Care AB (publ) | Corp. ID No. 556757-1103
Södra Hamngatan 45 | SE-411 06 Gothenburg | Sweden
Tel +46-31 712 53 00 | Fax +46-31 313 13 21 | www.ghp.se
This report has not been the subject of review by the company’s auditor.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.
Denna information skickades av Cision http://newsroom.cision.com
Filer att ladda ned:Dag Andersson proposed new Board Member of GHP